Condition
Cortico Basal Degeneration
Total Trials
4
Recruiting
2
Active
2
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 4 trials
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
2Total
Not Applicable (2)
Trial Status
Enrolling By Invitation2
Recruiting2
Clinical Trials (4)
Showing 4 of 4 trials
NCT07222605Not ApplicableEnrolling By Invitation
Research Study for Patients With Neurological Diseases Which Evaluates the Patient Experience of the MemorEM Device
NCT07049341Not ApplicableEnrolling By Invitation
Pilot Trial Evaluating Patient Experience With the MemorEM for Patients With Neurological Diseases
NCT07000851RecruitingPrimary
Imaging Studies in Corticobasal Syndrome
NCT06645626Recruiting
Utilisation of Health Services and Quality of Life in Patients With Atypical Parkinsonian Syndromes
Showing all 4 trials